Cover Image
市場調查報告書

末期腎功能衰竭 (ESRD) :全球臨床實驗趨勢

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 326148
出版日期 內容資訊 英文 103 Pages
訂單完成後即時交付
價格
Back to Top
末期腎功能衰竭 (ESRD) :全球臨床實驗趨勢 End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015
出版日期: 2015年09月10日 內容資訊: 英文 103 Pages
簡介

本報告提供末期腎功能衰竭 (ESRD) 相關之臨床研究最新趨勢調查,提供您地區·進展·Phase·募集情況別的實驗量,並彙整代表性贊助商,開發中的治療藥資訊,全球各國的主要企業·機關進展,有潛力的藥劑比較等資訊。

簡介

  • 末期腎功能衰竭 (ESRD)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5國的臨床實驗數量
    • 中南美主要5國的臨床實驗數量

G7各國臨床實驗數量:泌尿生殖系統系及性荷爾蒙相關臨床實驗上,末期腎功能衰竭 (ESRD) 的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:泌尿生殖系統系及性荷爾蒙相關臨床實驗上,末期腎功能衰竭 (ESRD) 的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別臨床實驗數量

有潛力的贊助商

末期腎功能衰竭 (ESRD) 治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Amgen Inc.
    • Novartis AG
    • F. Hoffmann-La Roche Ltd.
    • AstraZeneca PLC
    • Pfizer Inc.
    • Sanofi
    • Shire Plc
    • Merck & Co., Inc.
    • Baxter International Inc.
    • AbbVie Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Vanderbilt University
    • Isfahan University of Medical Sciences
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Massachusetts General Hospital
    • Ege University
    • Shiraz University of Medical Sciences
    • The National Institute of Allergy and Infectious Diseases
    • The University of Hong Kong
    • University of Michigan
    • University of Washington

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2853CTIDB

GlobalData's clinical trial report, "End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2015" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • DaVita HealthCare Partners Inc.
      • Clinical Trial Overview of DaVita HealthCare Partners Inc.
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Isfahan University of Medical Sciences
      • Clinical Trial Overview of Isfahan University of Medical Sciences
      • Shiraz University of Medical Sciences
      • Clinical Trial Overview of Shiraz University of Medical Sciences
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • University of Alberta
      • Clinical Trial Overview of University of Alberta
      • Ahvaz Jundishapur University of Medical Sciences
      • Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences
      • Centre Hospitalier Universitaire Vaudois
      • Clinical Trial Overview of Centre Hospitalier Universitaire Vaudois
      • Columbia University
      • Clinical Trial Overview of Columbia University
      • Creighton University
      • Clinical Trial Overview of Creighton University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Suspended Clinical Trials, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Terminated Clinical Trials, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by DaVita HealthCare Partners Inc., 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire Vaudois, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2015*

List of Figures

  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top